Gestational age (preterm birth < 37 weeks) · healthy pregnant women receiving calcium supplementation vs placebo or no treatment
Calcium supplementation showed no clear difference in preterm birth (a) Birth prior to 37 weeks compared with placebo or no treatment (maternal outcomes) (moderate certainty).
1 finding from 1 review
Preterm birth less than 34 weeks' gestation · healthy pregnant women receiving calcium supplementation vs placebo or no treatment
Calcium supplementation showed no clear difference in preterm birth (b) Birth prior to 34 weeks compared with placebo or no treatment (maternal outcomes) (moderate certainty).
1 finding from 1 review
Low birthweight · healthy pregnant women receiving calcium supplementation vs placebo or no treatment
Calcium supplementation showed no clear difference in low birthweight (< 2500 g) compared with placebo or no treatment (maternal outcomes) (moderate certainty).
1 finding from 1 review
Chorioamnionitis Clinical findings · Pregnant women with a gestational age greater than 28 weeks, considered to be in labour receiving chlorhexidine vaginal douching during…
Chlorhexidine vaginal wash showed no clear difference in chorioamnionitis Clinical findings compared with placebo (moderate certainty).
1 finding from 1 review
Postpartum endometritis Clinical findings · Pregnant women with a gestational age greater than 28 weeks, considered to be in labour receiving chlorhexidine vaginal douching during…
Chlorhexidine vaginal wash showed no clear difference in postpartum endometritis Clinical findings compared with placebo (moderate certainty).
1 finding from 1 review
Neonatal sepsis · Pregnant women with a gestational age greater than 28 weeks, considered to be in labour receiving chlorhexidine vaginal douching during…
Chlorhexidine vaginal wash showed no clear difference in neonatal sepsis Clinical findings compared with placebo (low certainty).
1 finding from 1 review
Blood culture confirming neonatal sepsis Clinical findings and confirmation by laboratory · Pregnant women with a gestational age greater than 28 weeks, considered to be in labour receiving chlorhexidine vaginal douching during…
Chlorhexidine vaginal wash showed no clear difference in blood culture confirming neonatal sepsis Clinical findings and… compared with placebo (low certainty).
1 finding from 1 review
All‐cause mortality · pregnant women with fetal growth restriction
Sildenafil citrate showed no clear difference in all‐cause mortality compared with placebo or no therapy (moderate certainty).
1 finding from 1 review
Fetal mortality · pregnant women with fetal growth restriction
Sildenafil citrate showed no clear difference in fetal mortality compared with placebo or no therapy (moderate certainty).
1 finding from 1 review
Neonatal mortality · pregnant women with fetal growth restriction
Sildenafil citrate showed no clear difference in neonatal mortality compared with placebo or no therapy (moderate certainty).
1 finding from 1 review
All‐cause mortality · pregnant women with fetal growth restriction
Tadalafil showed no clear difference in all‐cause mortality compared with placebo or no therapy (low certainty).
1 finding from 1 review
Fetal mortality · pregnant women with fetal growth restriction
Tadalafil showed no clear difference in fetal mortality compared with placebo or no therapy (low certainty).
1 finding from 1 review
Neonatal mortality · pregnant women with fetal growth restriction
Tadalafil showed no clear difference in neonatal mortality compared with placebo or no therapy (low certainty).
1 finding from 1 review
All‐cause mortality · pregnant women with fetal growth restriction
1 finding from 1 review
Fetal mortality · pregnant women with fetal growth restriction
1 finding from 1 review
Neonatal mortality · pregnant women with fetal growth restriction
1 finding from 1 review
Death (fetal, neonatal, or later (up to 2 years' corrected age))** · women at risk of preterm birth (< 34 weeks' gestation)
Magnesium sulphate showed no clear difference in death (fetal, neonatal, or later (up to 2 years' corrected age))** compared with placebo (outcomes (moderate certainty).
1 finding from 1 review
Death or cerebral palsy · women at risk of preterm birth (< 34 weeks' gestation)
Magnesium sulphate showed no clear difference in death or cerebral palsy (up to school age)** compared with placebo (outcomes (low certainty).
2 findings from 1 review
Major neurodevelopmental disability at childhood · women at risk of preterm birth (< 34 weeks' gestation)
It is very uncertain whether magnesium sulphate changes major neurodevelopmental disability (school age)** compared with placebo (outcomes (very low certainty).
1 finding from 1 review
Death or major neurodevelopmental disability · women at risk of preterm birth (< 34 weeks' gestation)
Magnesium sulphate showed no clear difference in death or major neurodevelopmental disability (up to school age)** compared with placebo (outcomes (low certainty).
2 findings from 1 review